| Investor Type | Firm |
| Type of Fund | Corporate VC |
| Stages | Seed |
Lundbeckfonden is a corporate venture capital fund headquartered in Denmark with a focus on seed investments. As an active participant in the realm of business and science, they invest in groundbreaking science with the potential to deliver significant impact.
Their investment strategy revolves around the principle of 'Bringing Discoveries to Lives', which underscores their commitment to supporting scientific advances that can translate into real-world applications, especially in healthcare. With the aspiration of doubling their annual research grants in Denmark by 2030, their focus is particularly strategic towards brain research, aiming to establish clearer focus on neuroscience. They also plan to expand their portfolio of long-term ownerships in the healthcare sector, striving to become leaders at the international stage originating from Denmark.
Collaborating closely with the research and business community is a cornerstone of their approach to create powerful ripple effects that foster the translation of discoveries into practical solutions. Lundbeckfonden grants over 500 million DKK annually to health science research primarily centered on the brain, facilitating the commercialization of innovative science through both local and international investments and partnerships.
Additionally, they support significant educational initiatives like the Neuroscience Academy Denmark, aiming to elevate neuroscientific research through talent development and collaborative efforts across various institutions. Their grant programs span a wide spectrum, such as Fellowships, Professorships, Ascending Investigators, Pre-Graduate Scholarships, and several distinguished awards like The Brain Prize, which celebrates outstanding contributions to neuroscience. Through their subsidiary, Lundbeckfonden BioCapital, they help in the commercialization of cutting-edge biotech science.
Besides investments, they actively engage in strategic ownerships of healthcare companies, with a long-term vision to foster leaders with global influence based out of Denmark. Their portfolio includes risk-taking projects like 'Experiments 2024', which awarded 60 million DKK for daring ideas in neuroscience, and 'Collaboratives 2024', allocating 120 million DKK for interdisciplinary brain research projects.

